Jupiter Life Line Hospitals Limited
Jupiter Life Line Hospitals Limited Fundamental Analysis
Jupiter Life Line Hospitals Limited (JLHL.BO) shows moderate financial fundamentals with a PE ratio of 44.35, profit margin of 12.99%, and ROE of 13.61%. The company generates $14.9B in annual revenue with strong year-over-year growth of 17.96%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 58.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze JLHL.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakJLHL.BO struggles to generate sufficient returns from assets.
Valuation Score
WeakJLHL.BO trades at a premium to fair value.
Growth Score
ModerateJLHL.BO shows steady but slowing expansion.
Financial Health Score
ExcellentJLHL.BO maintains a strong and stable balance sheet.
Profitability Score
WeakJLHL.BO struggles to sustain strong margins.
Key Financial Metrics
Is JLHL.BO Expensive or Cheap?
P/E Ratio
JLHL.BO trades at 44.35 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, JLHL.BO's PEG of 163.59 indicates potential overvaluation.
Price to Book
The market values Jupiter Life Line Hospitals Limited at 5.58 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 21.84 times EBITDA. This signals the market has high growth expectations.
How Well Does JLHL.BO Make Money?
Net Profit Margin
For every $100 in sales, Jupiter Life Line Hospitals Limited keeps $12.99 as profit after all expenses.
Operating Margin
Core operations generate 17.09 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $13.61 in profit for every $100 of shareholder equity.
ROA
Jupiter Life Line Hospitals Limited generates $8.15 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Jupiter Life Line Hospitals Limited generates limited operating cash flow of $1.30B, signaling weaker underlying cash strength.
Free Cash Flow
Jupiter Life Line Hospitals Limited generates weak or negative free cash flow of $-403.60M, restricting financial flexibility.
FCF Per Share
Each share generates $-6.16 in free cash annually.
FCF Yield
JLHL.BO converts -0.47% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
44.35
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
163.59
vs 25 benchmark
P/B Ratio
Price to book value ratio
5.58
vs 25 benchmark
P/S Ratio
Price to sales ratio
5.76
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.38
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.02
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.14
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.12
vs 25 benchmark
How JLHL.BO Stacks Against Its Sector Peers
| Metric | JLHL.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 44.35 | 29.05 | Worse (Expensive) |
| ROE | 13.61% | 746.00% | Weak |
| Net Margin | 12.99% | -49773.00% (disorted) | Strong |
| Debt/Equity | 0.38 | 0.40 | Neutral |
| Current Ratio | 3.02 | 4.00 | Strong Liquidity |
| ROA | 8.15% | -21585.00% (disorted) | Weak |
JLHL.BO outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Jupiter Life Line Hospitals Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
134.93%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
462.08%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
347.56%
Industry Style: Defensive, Growth, Innovation
High Growth